Showing 3751-3760 of 4063 results for "".
- FDA Grants Priority Review Approval For Regeneron’s REGN-EB3 to Treat Ebolahttps://modernod.com/news/fda-crants-for-priority-review-approval-for-regenerons-regn-eb3-to-treat-ebola/2477599/Regeneron Pharmaceuticals announced that the FDA has accepted for priority review a new biologics license application (BLA) for REGN-EB3, an investigational triple antibody cocktail treatment for Ebola virus infection. The target action date for the FDA decision is October 25, 2020.
- Breakthrough Technology Used to Discover Eye Damage from Repeated Intravitreal Injectionshttps://modernod.com/news/breakthrough-technology-used-to-discover-eye-damage-from-repeated-intravitreal-injections/2477567/In a first of its kind study, Mount Sinai researchers are using optimal coherence tomography angiography (OCTA) to measure potential retina damage from long-term use of intravitreal eye injections. The findings, published in the April issue of Retina, suggest that repeated use of these i
- Contact Lens Institute Shares New CDC Guidance for Contact Lens Wear and COVID-19https://modernod.com/news/contact-lens-institute-shares-new-cdc-guidance-for-contact-lens-wear-and-covid-19/2477563/The Contact Lens Institute is sharing new guidance issued this week by the U.S. Centers for Disease Control and Prevention (CDC) regarding contact lens wear and care amid the COVID-19 pandemic. The direction,
- Glaukos Provides Update on COVID-19 Impact and Preliminary Net Sales Range for First Quarterhttps://modernod.com/news/glaukos-provides-update-on-covid-19-impact-and-preliminary-net-sales-range-for-first-quarter/2477552/Glaukos provided an update on the impact of the COVID-19 pandemic on the company and announced a preliminary net sales range for its first quarter of 2020. Preliminary and Unaudited First Quarter 2020 Net Sales and COVID-19 Response Preliminary and unaudited net sales for the
- Icare USA Completes Merger with CenterVuehttps://modernod.com/news/icare-usa-completes-merger-with-centervue/2477549/Icare USA announced that it has completed its merger with CenterVue after the acquisition of CenterVue by Revenio Group Corporation in April 2019. Financial terms of the deal were not disclosed. In March 2020, the two corporations were consolidated under a single management team. Co
- AMA Suspends Plans for Annual Meeting in Chicagohttps://modernod.com/news/ama-suspends-plans-for-annual-meeting-in-chicago/2479528/The American Medical Association’s 2020 Annual Meeting planned for June in Chicago has been suspended due to the COVID-19 pandemic, according to a FierceHealthcare report. The AMA s
- WSJ: Trump Administration Plans to Pay Hospitals to Treat Uninsured Coronavirus Patientshttps://modernod.com/news/wsj-trump-administration-plans-to-pay-hospitals-to-treat-uninsured-coronavirus-patients/2477529/The Trump administration is expected to use a federal stimulus package to pay hospitals that treat uninsured people with the new coronavirus as long as they agree not to bill the patients or issue unexpected charges, The Wall Street Journal
- Vision Expo Announces Virtual Connections Program to Launch in Mid-Aprilhttps://modernod.com/news/vision-expo-announces-virtual-connections-program-to-launch-in-mid-april/2477509/Vision Expo has announced it will launch Virtual Connections, a new program designed to encourage and facilitate conversations and virtual meetings for Vision Expo East 2020 exhibitors and attendees who had registered for the event that was postponed as a result of COVID-19, according to a Vision
- FDA Approves Anti-Malarial Drugs Chloroquine And Hydroxychloroquine For Emergency Coronavirus Treatmenthttps://modernod.com/news/fda-approves-anti-malarial-drugs-chloroquine-and-hydroxychloroquine-for-emergency-coronavirus-treatment/2477496/The Food and Drug Administration on Sunday issued an emergency authorization for experimental coronavirus treatments using chloroquine and hydroxychloroquine, anti-malaria drugs touted by President Donald Trump despite inconclusive clinical proof of their effectiveness, according to a Forbes
- OOTG Webcast: Weathering the Storm and Supporting Staffhttps://modernod.com/news/ootg-webcast-weathering-the-storm-and-supporting-staff/2477488/“Ophthalmology off the Grid” cohosts Gary Wörtz, MD, and Blake Williamson, MD, MPH, sat down—virtually—with Robert Weinstock, MD, and Elizabeth Yeu, MD, on March 27 to discuss how the COVID-19 crisis is